Drug-induced liver injury (DILI) is a rare but potentially life threatening adverse drug reaction. DILI may mimic any morphologic characteristic of acute or chronic liver disease, and the histopathologic features of DILI may be indistinguishable from those of other causes of liver injury, such as acute viral hepatitis. In this review article, we provide an update on causative agents, clinical features, pathogenesis, diagnosis modalities, and outcomes of DILI. In addition, we review results of recently reported genetic studies and updates on pharmacological and invasive treatments
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions and ca...
Drug-induced liver injury (DILI) is a rare but potentially life threatening adverse drug reaction. D...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
Drug-induced liver injury (Dili) is among the most challenging acute or chronic liver conditions to ...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
Drug-induced liver injury (Dili) is among the most challenging acute or chronic liver conditions to ...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109945/1/cptclpt2010100.pd
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions and ca...
Drug-induced liver injury (DILI) is a rare but potentially life threatening adverse drug reaction. D...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
Purpose of review: The pathogenesis of DILI is currently unknown however research has shown strong g...
Drug-induced liver injury (Dili) is among the most challenging acute or chronic liver conditions to ...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
A number of drug-specific and host-related factors contribute to the development of drug-induced liv...
Drug-induced liver injury (Dili) is among the most challenging acute or chronic liver conditions to ...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/109945/1/cptclpt2010100.pd
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Drug-induced liver injury (DILI) is one of the most common and serious adverse drug reactions and ca...